Viewing Study NCT01968668


Ignite Creation Date: 2025-12-24 @ 5:49 PM
Ignite Modification Date: 2026-01-23 @ 8:42 AM
Study NCT ID: NCT01968668
Status: COMPLETED
Last Update Posted: 2021-07-16
First Post: 2013-10-21
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Safety and Efficacy of Different Oral Doses of BAY94-8862 in Japanese Subjects With Type 2 Diabetes Mellitus and the Clinical Diagnosis of Diabetic Nephropathy (ARTS-DN Japan)
Sponsor: Bayer
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Diabetic Nephropathies View
Keywords:

Keywords

Keyword Brief Keyword Text View
None BAY94-8862 View
None MR antagonist View
None Diabetic nephropathy View
None Japanese patients View